Cargando…
Bamlanivimab infusion experience at one academic emergency department
Autores principales: | Yoo, Michael J., Long, Brit J., Schauer, Steven G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
W B Saunders
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274276/ https://www.ncbi.nlm.nih.gov/pubmed/34294501 http://dx.doi.org/10.1016/j.ajem.2021.06.076 |
Ejemplares similares
-
Development of a Bamlanivimab Infusion Process in the Emergency Department for Outpatient COVID-19 Patients
por: Pham, Danny H., et al.
Publicado: (2021) -
The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting
por: Corwin, Douglas S, et al.
Publicado: (2021) -
500. A Real-World Cohort Study of Bamlanivimab Versus Bamlanivimab-Etesevimab for Non-severe COVID-19
por: Monday, Lea, et al.
Publicado: (2021) -
‘Swab and Go’ impact on emergency department left without being seen rates
por: Yoo, Michael J., et al.
Publicado: (2022) -
BAMLANIVIMAB-INDUCED GUILLAIN-BARRÉ SYNDROME
por: PALAGUACHI, GLADYS, et al.
Publicado: (2021)